SynthesisInternational journal of cancer2026

Clinical Benefit and Safety of Combined Immunotherapy and Targeted Therapy in Prostate Cancer.

Zeyu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.